These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 2093889
1. [Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma]. Guerra P. Pediatr Med Chir; 1990; 12(6):663-8. PubMed ID: 2093889 [Abstract] [Full Text] [Related]
2. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy. Voûte PA, Hoefnagel CA, de Kraker J, Valdes Olmos R, Bakker DJ, van de Kleij AJ. Prog Clin Biol Res; 1991; 366():439-45. PubMed ID: 2068157 [No Abstract] [Full Text] [Related]
3. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine. Edeling CJ, Büchler Frederiksen P, Kamper J, Jeppesen P. Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256 [Abstract] [Full Text] [Related]
4. [Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine]. Klingebiel T, Reuland P, Feine U, Niethammer D. Nuklearmedizin; 1992 Dec; 31(6):209-12. PubMed ID: 1491958 [Abstract] [Full Text] [Related]
12. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans. Gordon I, Peters AM, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J. J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350 [Abstract] [Full Text] [Related]
13. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis. Schwarz KB, Driver I, Lewis IJ, Taylor RE. Br J Radiol; 1997 Jan; 70():90-2. PubMed ID: 9059302 [Abstract] [Full Text] [Related]